---
document_datetime: 2023-09-21 19:55:06
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/xiapex-epar-all-authorised-presentations_en.pdf
document_name: xiapex-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.6842108
conversion_datetime: 2025-12-24 07:15:15.369404
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| EU Number       | (Invented) name   | Strength   | Pharmaceutical Form                           | Route of Administration   | Packaging                                  | Content (concentration)    | Package size    |
|-----------------|-------------------|------------|-----------------------------------------------|---------------------------|--------------------------------------------|----------------------------|-----------------|
| EU/1/11/671/001 | Xiapex            | 0.9 mg     | Powder and solvent for solution for injection | Intralesional use         | powder: vial (glass) solvent: vial (glass) | powder: 3 ml solvent: 5 ml | 1 vial + 1 vial |

<!-- image -->